CVRx, Inc. (CVRX)
NASDAQ: CVRX · IEX Real-Time Price · USD
8.29
+0.21 (2.60%)
At close: May 17, 2024, 4:00 PM
8.10
-0.19 (-2.29%)
After-hours: May 17, 2024, 5:36 PM EDT
CVRx, Inc. Revenue
CVRx, Inc. had revenue of $42.09M in the twelve months ending March 31, 2024, with 59.59% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $10.77M with 34.98% year-over-year growth. In the year 2023, CVRx, Inc. had annual revenue of $39.30M with 74.89% growth.
Revenue (ttm)
$42.09M
Revenue Growth
+59.59%
P/S Ratio
4.26
Revenue / Employee
$210,430
Employees
200
Market Cap
179.24M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 39.30M | 16.83M | 74.89% |
Dec 31, 2022 | 22.47M | 9.43M | 72.36% |
Dec 31, 2021 | 13.04M | 6.98M | 115.36% |
Dec 31, 2020 | 6.05M | -204.00K | -3.26% |
Dec 31, 2019 | 6.26M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Lifecore Biomedical | 103.27M |
Biodesix | 54.85M |
Stereotaxis | 27.10M |
Zomedica | 25.97M |
Abeona Therapeutics | 3.50M |
Orchestra BioMed Holdings | 2.22M |
CVRX News
- 1 day ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. - CVRX - PRNewsWire
- 2 days ago - CVRx Announces Key Senior Leadership Team Hires - GlobeNewsWire
- 18 days ago - CVRx Reports First Quarter 2024 Financial and Operating Results - GlobeNewsWire
- 4 weeks ago - CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024 - GlobeNewsWire
- 4 weeks ago - CVRx announces availability of additional data supporting long-term benefits of Barostim - GlobeNewsWire
- 3 months ago - CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer - GlobeNewsWire
- 4 months ago - CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results - GlobeNewsWire
- 4 months ago - CVRx to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call on January 25th, 2024 - GlobeNewsWire